David Wolk - Publications

University of Pennsylvania, Philadelphia, PA, United States 
Memory, aging, Alzheimer's disease

163 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Ravikumar S, Denning AE, Lim S, Chung E, Sadeghpour N, Ittyerah R, Wisse LEM, Das SR, Xie L, Robinson JL, Schuck T, Lee EB, Detre JA, Tisdall MD, Prabhakaran K, ... ... Wolk DA, et al. Postmortem imaging reveals patterns of medial temporal lobe vulnerability to tau pathology in Alzheimer's disease. Nature Communications. 15: 4803. PMID 38839876 DOI: 10.1038/s41467-024-49205-0  0.309
2024 Katsumi Y, Howe IA, Eckbo R, Wong B, Quimby M, Hochberg D, McGinnis SM, Putcha D, Wolk DA, Touroutoglou A, Dickerson BC. Default mode network tau predicts future clinical decline in atypical early Alzheimer's disease. Medrxiv : the Preprint Server For Health Sciences. PMID 38699357 DOI: 10.1101/2024.04.17.24305620  0.33
2024 Phillips JS, Adluru N, Chung MK, Radhakrishnan H, Olm CA, Cook PA, Gee JC, Cousins KAQ, Arezoumandan S, Wolk DA, McMillan CT, Grossman M, Irwin DJ. Greater white matter degeneration and lower structural connectivity in non-amnestic vs. amnestic Alzheimer's disease. Frontiers in Neuroscience. 18: 1353306. PMID 38567286 DOI: 10.3389/fnins.2024.1353306  0.341
2024 Arezoumandan S, Cousins KAQ, Ohm DT, Lowe M, Chen M, Gee J, Phillips JS, McMillan CT, Luk KC, Deik A, Spindler MA, Tropea TF, Weintraub D, Wolk DA, Grossman M, et al. Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease. Annals of Clinical and Translational Neurology. PMID 38263854 DOI: 10.1002/acn3.51988  0.307
2023 Lyu X, Duong MT, Xie L, de Flores R, Richardson H, Hwang G, Wisse LEM, DiCalogero M, McMillan CT, Robinson JL, Xie SX, Lee EB, Irwin DJ, Dickerson BC, Davatzikos C, ... ... Wolk DA, et al. Tau-neurodegeneration mismatch reveals vulnerability and resilience to comorbidities in Alzheimer's continuum. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 38050662 DOI: 10.1002/alz.13559  0.303
2023 Phillips JS, Robinson JL, Cousins KAQ, Wolk DA, Lee EB, McMillan CT, Trojanowski JQ, Grossman M, Irwin DJ. Polypathologic associations with grey matter atrophy in neurodegenerative disease. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 38050082 DOI: 10.1523/JNEUROSCI.0808-23.2023  0.312
2023 Touroutoglou A, Katsumi Y, Brickhouse M, Zaitsev A, Eckbo R, Aisen P, Beckett L, Dage JL, Eloyan A, Foroud T, Ghetti B, Griffin P, Hammers D, Jack CR, Kramer JH, ... ... Wolk DA, et al. The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37850549 DOI: 10.1002/alz.13466  0.3
2023 Nudelman KNH, Jackson T, Rumbaugh M, Eloyan A, Abreu M, Dage JL, Snoddy C, Faber KM, Foroud T, Hammers DB, Taurone A, Thangarajah M, Aisen P, Beckett L, Kramer J, ... ... Wolk DA, et al. Pathogenic variants in the Longitudinal Early-onset Alzheimer's Disease Study cohort. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37801072 DOI: 10.1002/alz.13482  0.306
2023 Kang JH, Korecka M, Lee EB, Cousins KAQ, Tropea TF, Chen-Plotkin AA, Irwin DJ, Wolk D, Brylska M, Wan Y, Shaw LM. Alzheimer Disease Biomarkers: Moving from CSF to Plasma for Reliable Detection of Amyloid and tau Pathology. Clinical Chemistry. PMID 37725909 DOI: 10.1093/clinchem/hvad139  0.318
2023 Cho H, Mundada NS, Apostolova LG, Carrillo MC, Shankar R, Amuiri AN, Zeltzer E, Windon CC, Soleimani-Meigooni DN, Tanner JA, Heath CL, Lesman-Segev OH, Aisen P, Eloyan A, Lee HS, ... ... Wolk DA, et al. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37690109 DOI: 10.1002/alz.13453  0.334
2023 Nemes S, Logan PE, Manchella MK, Mundada NS, La Joie R, Polsinelli AJ, Hammers DB, Koeppe RA, Foroud TM, Nudelman KN, Eloyan A, Iaccarino L, Dorsant-Ardón V, Taurone A, Thangarajah M, ... ... Wolk DA, et al. Sex and APOE ε4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37496307 DOI: 10.1002/alz.13403  0.323
2023 Dage JL, Eloyan A, Thangarajah M, Hammers DB, Fagan AM, Gray JD, Schindler SE, Snoddy C, Nudelman KNH, Faber KM, Foroud T, Aisen P, Griffin P, Grinberg LT, Iaccarino L, ... ... Wolk DA, et al. Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37491668 DOI: 10.1002/alz.13399  0.308
2023 Eloyan A, Thangarajah M, An N, Borowski BJ, Reddy AL, Aisen P, Dage JL, Foroud T, Ghetti B, Griffin P, Hammers D, Iaccarino L, Jack CR, Kirby K, Kramer J, ... ... Wolk DA, et al. White matter hyperintensities are higher among early-onset Alzheimer's disease participants than their cognitively normal and early-onset nonAD peers: Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37491599 DOI: 10.1002/alz.13402  0.353
2023 Hammers DB, Eloyan A, Taurone A, Thangarajah M, Beckett L, Gao S, Kirby K, Aisen P, Dage JL, Foroud T, Griffin P, Grinberg LT, Jack CR, Kramer J, Koeppe R, ... ... Wolk DA, et al. Profiling baseline performance on the Longitudinal Early-Onset Alzheimer's Disease Study (LEADS) cohort near the midpoint of data collection. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37256497 DOI: 10.1002/alz.13160  0.33
2023 Nelson PT, Schneider JA, Jicha GA, Duong MT, Wolk DA. When Alzheimer's is LATE: Why does it matter? Annals of Neurology. PMID 37245084 DOI: 10.1002/ana.26711  0.333
2023 Xie L, Das SR, Wisse LEM, Ittyerah R, de Flores R, Shaw LM, Yushkevich PA, Wolk DA. Baseline structural MRI and plasma biomarkers predict longitudinal structural atrophy and cognitive decline in early Alzheimer's disease. Alzheimer's Research & Therapy. 15: 79. PMID 37041649 DOI: 10.1186/s13195-023-01210-z  0.349
2023 Cousins KAQ, Irwin DJ, Chen-Plotkin A, Shaw LM, Arezoumandan S, Lee EB, Wolk DA, Weintraub D, Spindler M, Deik A, Grossman M, Tropea TF. Plasma GFAP associates with secondary Alzheimer's pathology in Lewy body disease. Annals of Clinical and Translational Neurology. PMID 37000892 DOI: 10.1002/acn3.51768  0.344
2023 Largent EA, Grill J, O'Brien K, Wolk D, Harkins K, Karlawish J. Testing for Alzheimer Disease Biomarkers and Disclosing Results Across the Disease Continuum. Neurology. PMID 36720642 DOI: 10.1212/WNL.0000000000206891  0.318
2022 Ko YA, Billheimer JT, Lyssenko NN, Kueider-Paisley A, Wolk DA, Arnold SE, Leung YY, Shaw LM, Trojanowski JQ, Kaddurah-Daouk RF, Kling MA, Rader DJ. ApoJ/Clusterin concentrations are determinants of cerebrospinal fluid cholesterol efflux capacity and reduced levels are associated with Alzheimer's disease. Alzheimer's Research & Therapy. 14: 194. PMID 36572909 DOI: 10.1186/s13195-022-01119-z  0.494
2022 Tropea TF, Waligorska T, Xie SX, Nasrallah IM, Cousins KAQ, Trojanowski JQ, Grossman M, Irwin DJ, Weintraub D, Lee EB, Wolk DA, Chen-Plotkin AS, Shaw LM. Plasma phosphorylated tau181 predicts cognitive and functional decline. Annals of Clinical and Translational Neurology. PMID 36518085 DOI: 10.1002/acn3.51695  0.321
2022 Duong MT, Wolk DA. Limbic-Predominant Age-Related TDP-43 Encephalopathy: LATE-Breaking Updates in Clinicopathologic Features and Biomarkers. Current Neurology and Neuroscience Reports. PMID 36190653 DOI: 10.1007/s11910-022-01232-4  0.33
2022 Quilico Cousins KA, Arezoumandan S, Shellikeri S, Ohm D, Shaw LM, Grossman M, Wolk D, McMillan CT, Chen-Plotkin A, Lee E, Trojanowski JQ, Zetterberg H, Blennow K, Irwin DJ. CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology. Neurology. PMID 36041863 DOI: 10.1212/WNL.0000000000201202  0.308
2022 Shellikeri S, Cho S, Cousins KAQ, Liberman M, Howard E, Balganorth Y, Weintraub D, Spindler M, Deik A, Lee EB, Trojanowski JQ, Irwin D, Wolk D, Grossman M, Nevler N. Natural speech markers of Alzheimer's disease co-pathology in Lewy body dementias. Parkinsonism & Related Disorders. 102: 94-100. PMID 35985146 DOI: 10.1016/j.parkreldis.2022.07.023  0.337
2022 Walker IM, Cousins KA, Siderowf A, Duda JE, Morley JF, Dahodwala N, Tropea T, Vaishnavi S, Wolk DA, Chen-Plotkin AS, Shaw LM, Lee EB, Trojanowski JQ, Grossman M, Weintraub D, et al. Non-tremor motor dysfunction in Lewy body dementias is associated with AD biomarkers. Parkinsonism & Related Disorders. 100: 33-36. PMID 35700626 DOI: 10.1016/j.parkreldis.2022.05.022  0.329
2022 Hwang G, Abdulkadir A, Erus G, Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Rashid T, Bilgel M, Fan Y, Sotiras A, Srinivasan D, Morris JC, Albert MS, ... ... Wolk DA, et al. Disentangling Alzheimer's disease neurodegeneration from typical brain ageing using machine learning. Brain Communications. 4: fcac117. PMID 35611306 DOI: 10.1093/braincomms/fcac117  0.375
2022 Pichet Binette A, Palmqvist S, Bali D, Farrar G, Buckley CJ, Wolk DA, Zetterberg H, Blennow K, Janelidze S, Hansson O. Combining plasma phospho-tau and accessible measures to evaluate progression to Alzheimer's dementia in mild cognitive impairment patients. Alzheimer's Research & Therapy. 14: 46. PMID 35351181 DOI: 10.1186/s13195-022-00990-0  0.374
2021 Mechanic-Hamilton D, Lydon S, Miller A, Halberstadter K, DiCalogero M, Wolk DA. Development and pilot data for an app-based cognitive assessment for detecting memory and executive functioning changes in aging and pre-clinical AD. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 17: e056618. PMID 34971050 DOI: 10.1002/alz.056618  0.361
2021 Uemura MT, Robinson JL, Cousins KAQ, Tropea TF, Kargilis DC, McBride JD, Suh E, Xie SX, Xu Y, Porta S, Uemura N, Van Deerlin VM, Wolk DA, Irwin DJ, Brunden KR, et al. Distinct characteristics of limbic-predominant age-related TDP-43 encephalopathy in Lewy body disease. Acta Neuropathologica. PMID 34854996 DOI: 10.1007/s00401-021-02383-3  0.307
2021 Ravikumar S, Wisse LEM, Lim S, Ittyerah R, Xie L, Bedard ML, Das SR, Lee EB, Tisdall MD, Prabhakaran K, Lane J, Detre JA, Mizsei G, Trojanowski JQ, Robinson JL, ... ... Wolk DA, et al. Ex vivo MRI atlas of the human medial temporal lobe: characterizing neurodegeneration due to tau pathology. Acta Neuropathologica Communications. 9: 173. PMID 34689831 DOI: 10.1186/s40478-021-01275-7  0.318
2021 Das SR, Lyu X, Duong MT, Xie L, McCollum L, de Flores R, DiCalogero M, Irwin DJ, Dickerson BC, Nasrallah IM, Yushkevich PA, Wolk DA. Tau-atrophy variability reveals phenotypic heterogeneity in Alzheimer's disease. Annals of Neurology. PMID 34617306 DOI: 10.1002/ana.26233  0.334
2021 Duong MT, Chen YJ, Doot RK, Young AJ, Lee H, Cai J, Pilania A, Wolk DA, Nasrallah IM. Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology. Nuclear Medicine Communications. PMID 34231519 DOI: 10.1097/MNM.0000000000001460  0.357
2021 Klooster N, Humphries S, Cardillo E, Hartung F, Xie L, Das S, Yushkevich P, Pilania A, Wang J, Wolk DA, Chatterjee A. Sensitive Measures of Cognition in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 34151789 DOI: 10.3233/JAD-201280  0.359
2021 McCollum LE, Das SR, Xie L, de Flores R, Wang J, Xie SX, Wisse LEM, Yushkevich PA, Wolk DA. Oh brother, where art tau? Amyloid, neurodegeneration, and cognitive decline without elevated tau. Neuroimage. Clinical. 31: 102717. PMID 34119903 DOI: 10.1016/j.nicl.2021.102717  0.361
2021 Apostolova LG, Aisen P, Eloyan A, Fagan A, Fargo KN, Foroud T, Gatsonis C, Grinberg LT, Jack CR, Kramer J, Koeppe R, Kukull WA, Murray ME, Nudelman K, Rumbaugh M, ... ... Wolk DA, et al. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 34018654 DOI: 10.1002/alz.12350  0.372
2021 Nasrallah IM, Gaussoin SA, Pomponio R, Dolui S, Erus G, Wright CB, Launer LJ, Detre JA, Wolk DA, Davatzikos C, Williamson JD, Pajewski NM, Bryan RN. Association of Intensive vs Standard Blood Pressure Control With Magnetic Resonance Imaging Biomarkers of Alzheimer Disease: Secondary Analysis of the SPRINT MIND Randomized Trial. Jama Neurology. PMID 33683313 DOI: 10.1001/jamaneurol.2021.0178  0.306
2021 Howard E, Irwin DJ, Rascovsky K, Nevler N, Shellikeri S, Tropea TF, Spindler M, Deik A, Chen-Plotkin A, Siderowf A, Dahodwala N, Weintraub D, Shaw LM, Trojanowski JQ, Vaishnavi SN, ... Wolk DA, et al. Cognitive Profile and Markers of AD-Type Pathology in Patients with Lewy Body Dementias. Neurology. PMID 33593865 DOI: 10.1212/WNL.0000000000011699  0.331
2020 Robinson JL, Richardson H, Xie SX, Suh E, Van Deerlin VM, Alfaro B, Loh N, Porras-Paniagua M, Nirschl JJ, Wolk D, Lee VM, Lee EB, Trojanowski JQ. The development and convergence of co-pathologies in Alzheimer's disease. Brain : a Journal of Neurology. PMID 33449993 DOI: 10.1093/brain/awaa438  0.308
2020 Jain S, Rosenbaum PR, Reiter JG, Hoffman G, Small DS, Ha J, Hill AS, Wolk DA, Gaulton T, Neuman MD, Eckenhoff RG, Fleisher LA, Silber JH. Using Medicare claims in identifying Alzheimer's disease and related dementias. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33090695 DOI: 10.1002/alz.12199  0.331
2020 Coughlin DG, Phillips JS, Roll E, Peterson C, Lobrovich R, Rascovsky K, Ungrady M, Wolk DA, Das S, Weintraub D, Lee EB, Trojanowski JQ, Shaw LM, Vaishnavi S, Siderowf A, et al. Multimodal in vivo and postmortem assessments of tau in Lewy body disorders. Neurobiology of Aging. 96: 137-147. PMID 33002767 DOI: 10.1016/J.Neurobiolaging.2020.08.003  0.359
2020 Habes M, Pomponio R, Shou H, Doshi J, Mamourian E, Erus G, Nasrallah I, Launer LJ, Rashid T, Bilgel M, Fan Y, Toledo JB, Yaffe K, Sotiras A, Srinivasan D, ... ... Wolk DA, et al. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32920988 DOI: 10.1002/Alz.12178  0.307
2020 Coughlin DG, Ittyerah R, Peterson C, Phillips JS, Miller S, Rascovsky K, Weintraub DA, Siderowf AD, Duda JE, Hurtig HI, Wolk DA, McMillan C, Yushkevich PA, Grossman M, Lee EB, et al. Hippocampal Subfield Pathologic Burden in Lewy Body Diseases versus Alzheimer's Disease. Neuropathology and Applied Neurobiology. PMID 32892355 DOI: 10.1111/Nan.12659  0.341
2020 Xie L, Wisse LEM, Das SR, Vergnet N, Dong M, Ittyerah R, de Flores R, Yushkevich PA, Wolk DA. Longitudinal atrophy in early Braak regions in preclinical Alzheimer's disease. Human Brain Mapping. PMID 32845545 DOI: 10.1002/Hbm.25151  0.337
2020 Cousins KAQ, Irwin DJ, Wolk DA, Lee EB, Shaw LMJ, Trojanowski JQ, Da Re F, Gibbons GS, Grossman M, Phillips JS. ATN status in amnestic and non-amnestic Alzheimer's disease and frontotemporal lobar degeneration. Brain : a Journal of Neurology. PMID 32666090 DOI: 10.1093/Brain/Awaa165  0.333
2020 de Flores R, Wisse LEM, Das SR, Xie L, McMillan CT, Trojanowski JQ, Robinson JL, Grossman M, Lee E, Irwin DJ, Yushkevich PA, Wolk DA. Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 32323446 DOI: 10.1002/Alz.12079  0.307
2020 Habes M, Grothe MJ, Tunc B, McMillan C, Wolk DA, Davatzikos C. Disentangling Heterogeneity in Alzheimer's Disease and Related Dementias Using Data-Driven Methods. Biological Psychiatry. PMID 32201044 DOI: 10.1016/J.Biopsych.2020.01.016  0.33
2020 Blenkinsop A, van der Flier WM, Wolk D, Lehmann M, Howard R, Frost C, Barnes J. Non-memory cognitive symptom development in Alzheimer's disease. European Journal of Neurology. PMID 32078209 DOI: 10.1111/ene.14185  0.422
2020 Richards KC, Vallabhaneni V, Moelter S, Davis EM, Morrison J, Lozano A, Hanlon A, Wang Y, Wolk D, Gooneratne N. 0861 Age, Race, And Continuous Positive Airway Pressure (CPAP) Confidence Score At 1-week Predict 3-month CPAP Adherence In Older Adults With Amnestic Mild Cognitive Impairment And Moderate To Severe Obstructive Sleep Apnea Sleep. 43: A328-A328. DOI: 10.1093/Sleep/Zsaa056.857  0.322
2019 Wolk D, Salloway S, Dickerson B. Putting the New Alzheimer Disease Amyloid, Tau, Neurodegeneration (AT[N]) Diagnostic System to the Test. Jama. 321: 2289-2291. PMID 31211328 DOI: 10.1001/jama.2019.7534  0.391
2019 Li H, Habes M, Wolk DA, Fan Y. A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal magnetic resonance imaging data. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 31201098 DOI: 10.1016/j.jalz.2019.02.007  0.364
2019 Phillips JS, Da Re F, Irwin DJ, McMillan CT, Vaishnavi SN, Xie SX, Lee EB, Cook PA, Gee JC, Shaw LM, Trojanowski JQ, Wolk DA, Grossman M. Longitudinal progression of grey matter atrophy in non-amnestic Alzheimer's disease. Brain : a Journal of Neurology. 142: 1701-1722. PMID 31135048 DOI: 10.1093/Brain/Awz091  0.336
2019 Tropea TF, Mak J, Guo MH, Xie SX, Suh E, Rick J, Siderowf A, Weintraub D, Grossman M, Irwin D, Wolk DA, Trojanowski JQ, Van Deerlin V, Chen-Plotkin AS. TMEM106B Effect on Cognition in Parkinson's Disease and Frontotemporal Dementia. Annals of Neurology. PMID 30973966 DOI: 10.1002/Ana.25486  0.324
2019 McCollum L, Das SR, Xie L, Cui S, de Flores R, Wisse L, Yushkevich PA, Wolk DA. P4-068: AMYLOID-POSITIVE COGNITIVE IMPAIRMENT IS LESS “ALZHEIMER'S-LIKE” IN THE ABSENCE OF TAU Alzheimer's & Dementia. 15: P1299-P1299. DOI: 10.1016/J.Jalz.2019.06.3728  0.3
2018 Coughlin DG, Xie SX, Liang M, Williams A, Peterson C, Weintraub D, McMillan CT, Wolk DA, Akhtar RS, Hurtig H, Coslett HB, Hamilton R, Siderowf A, Duda JE, Rascovsky K, et al. Cognitive and Pathological Influences of Tau Pathology in Lewy Body Disorders. Annals of Neurology. PMID 30549331 DOI: 10.1002/Ana.25392  0.346
2018 Olsson B, Portelius E, Cullen NC, Sandelius Å, Zetterberg H, Andreasson U, Höglund K, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk D, McCluskey L, Elman L, Shaw LM, et al. Association of Cerebrospinal Fluid Neurofilament Light Protein Levels With Cognition in Patients With Dementia, Motor Neuron Disease, and Movement Disorders. Jama Neurology. PMID 30508027 DOI: 10.1001/Jamaneurol.2018.3746  0.351
2018 Sandelius Å, Portelius E, Källén Å, Zetterberg H, Rot U, Olsson B, Toledo JB, Shaw LM, Lee VMY, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk DA, McCluskey L, et al. Elevated CSF GAP-43 is Alzheimer's disease specific and associated with tau and amyloid pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 30321501 DOI: 10.1016/J.Jalz.2018.08.006  0.327
2018 Gangishetti U, Christina Howell J, Perrin RJ, Louneva N, Watts KD, Kollhoff A, Grossman M, Wolk DA, Shaw LM, Morris JC, Trojanowski JQ, Fagan AM, Arnold SE, Hu WT. Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer's disease. Alzheimer's Research & Therapy. 10: 98. PMID 30253800 DOI: 10.1186/S13195-018-0426-3  0.536
2018 Xie L, Das SR, Pilania A, Daffner M, Stockbower GE, Dolui S, Yushkevich PA, Detre JA, Wolk DA. Task-Enhanced Arterial Spin Labeled Perfusion MRI Predicts Longitudinal Neurodegeneration in Mild Cognitive Impairment. Hippocampus. PMID 30207006 DOI: 10.1002/Hipo.23026  0.323
2018 Leoutsakos JS, Yan H, Anderson WS, Asaad WF, Baltuch G, Burke A, Chakravarty MM, Drake KE, Foote KD, Fosdick L, Giacobbe P, Mari Z, McAndrews MP, Munro CA, Oh ES, ... ... Wolk D, et al. Deep Brain Stimulation Targeting the Fornix for Mild Alzheimer Dementia (the ADvance Trial): A Two Year Follow-up Including Results of Delayed Activation. Journal of Alzheimer's Disease : Jad. PMID 29914028 DOI: 10.3233/Jad-180121  0.355
2018 Barnes J, Bartlett JW, Wolk DA, van der Flier WM, Frost C. Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29914016 DOI: 10.3233/JAD-170841  0.308
2018 Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, Caswell C, Van Deerlin VM, Yan N, Yousef A, Hurtig HI, Siderowf A, Grossman M, McMillan CT, Miller B, ... ... Wolk D, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain : a Journal of Neurology. PMID 29878075 DOI: 10.1093/Brain/Awy146  0.56
2018 Wolk DA, Sadowsky C, Safirstein B, Rinne JO, Duara R, Perry R, Agronin M, Gamez J, Shi J, Ivanoiu A, Minthon L, Walker Z, Hasselbalch S, Holmes C, Sabbagh M, et al. Use of Flutemetamol F 18-Labeled Positron Emission Tomography and Other Biomarkers to Assess Risk of Clinical Progression in Patients With Amnestic Mild Cognitive Impairment. Jama Neurology. PMID 29799984 DOI: 10.1001/Jamaneurol.2018.0894  0.343
2018 Racine AM, Brickhouse M, Wolk DA, Dickerson BC. The personalized Alzheimer's disease cortical thickness index predicts likely pathology and clinical progression in mild cognitive impairment. Alzheimer's & Dementia (Amsterdam, Netherlands). 10: 301-310. PMID 29780874 DOI: 10.1016/j.dadm.2018.02.007  0.397
2018 Portelius E, Olsson B, Höglund K, Cullen NC, Kvartsberg H, Andreasson U, Zetterberg H, Sandelius Å, Shaw LM, Lee VMY, Irwin DJ, Grossman M, Weintraub D, Chen-Plotkin A, Wolk DA, et al. Cerebrospinal fluid neurogranin concentration in neurodegeneration: relation to clinical phenotypes and neuropathology. Acta Neuropathologica. PMID 29700597 DOI: 10.1007/S00401-018-1851-X  0.322
2018 Roalf DR, Rupert P, Mechanic-Hamilton D, Brennan L, Duda JE, Weintraub D, Trojanowski JQ, Wolk D, Moberg PJ. Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease. Journal of Neurology. PMID 29619565 DOI: 10.1007/S00415-018-8841-8  0.343
2018 Trombetta BA, Carlyle BC, Koenig AM, Shaw LM, Trojanowski JQ, Wolk DA, Locascio JJ, Arnold SE. The technical reliability and biotemporal stability of cerebrospinal fluid biomarkers for profiling multiple pathophysiologies in Alzheimer's disease. Plos One. 13: e0193707. PMID 29505610 DOI: 10.1371/Journal.Pone.0193707  0.521
2018 Klinger RY, James OG, Borges-Neto S, Bisanar T, Li YJ, Qi W, Berger M, Terrando N, Newman MF, Doraiswamy PM, Mathew JP, Weiner MW, Aisen P, Weiner M, Aisen P, ... ... Wolk DA, et al. 18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery. Anesthesiology. PMID 29389750 DOI: 10.1097/Aln.0000000000002103  0.462
2017 Jansen WJ, Ossenkoppele R, Tijms BM, Fagan AM, Hansson O, Klunk WE, van der Flier WM, Villemagne VL, Frisoni GB, Fleisher AS, Lleó A, Mintun MA, Wallin A, Engelborghs S, Na DL, ... ... Wolk DA, et al. Association of Cerebral Amyloid-β Aggregation With Cognitive Functioning in Persons Without Dementia. Jama Psychiatry. PMID 29188296 DOI: 10.1001/Jamapsychiatry.2017.3391  0.532
2017 Phillips JS, Das SR, McMillan CT, Irwin DJ, Roll EE, Da Re F, Nasrallah IM, Wolk DA, Grossman M. Tau PET imaging predicts cognition in atypical variants of Alzheimer's disease. Human Brain Mapping. PMID 29105977 DOI: 10.1002/Hbm.23874  0.371
2017 Stites SD, Karlawish J, Harkins K, Rubright JD, Wolk D. Awareness of Mild Cognitive Impairment and Mild Alzheimer's Disease Dementia Diagnoses Associated With Lower Self-Ratings of Quality of Life in Older Adults. The Journals of Gerontology. Series B, Psychological Sciences and Social Sciences. PMID 28958089 DOI: 10.1093/Geronb/Gbx100  0.366
2017 Irwin DJ, Lleó A, Xie SX, McMillan CT, Wolk D, Lee EB, Van Deerlin VM, Shaw LM, Trojanowski JQ, Grossman M. Ante mortem CSF tau levels correlate with post mortem tau pathology in FTLD. Annals of Neurology. PMID 28719018 DOI: 10.1002/Ana.24996  0.366
2017 Win KT, Pluta J, Yushkevich P, Irwin DJ, McMillan CT, Rascovsky K, Wolk D, Grossman M. Neural Correlates of Verbal Episodic Memory and Lexical Retrieval in Logopenic Variant Primary Progressive Aphasia. Frontiers in Neuroscience. 11: 330. PMID 28659753 DOI: 10.3389/Fnins.2017.00330  0.427
2017 Koenig AM, Mechanic-Hamilton D, Xie SX, Combs MF, Cappola AR, Xie L, Detre JA, Wolk DA, Arnold SE. Effects of the Insulin Sensitizer Metformin in Alzheimer Disease: Pilot Data From a Randomized Placebo-controlled Crossover Study. Alzheimer Disease and Associated Disorders. 31: 107-113. PMID 28538088 DOI: 10.1097/Wad.0000000000000202  0.533
2017 Giannini LAA, Irwin DJ, McMillan CT, Ash S, Rascovsky K, Wolk DA, Van Deerlin VM, Lee EB, Trojanowski JQ, Grossman M. Clinical marker for Alzheimer disease pathology in logopenic primary progressive aphasia. Neurology. PMID 28515265 DOI: 10.1212/Wnl.0000000000004034  0.326
2017 Dickerson BC, Brickhouse M, McGinnis S, Wolk DA. Alzheimer's disease: The influence of age on clinical heterogeneity through the human brain connectome. Alzheimer's & Dementia (Amsterdam, Netherlands). 6: 122-135. PMID 28239637 DOI: 10.1016/j.dadm.2016.12.007  0.334
2017 Roalf DR, Moore TM, Mechanic-Hamilton D, Wolk DA, Arnold SE, Weintraub DA, Moberg PJ. Bridging cognitive screening tests in neurologic disorders: A crosswalk between the short Montreal Cognitive Assessment and Mini-Mental State Examination. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 28238740 DOI: 10.1016/J.Jalz.2017.01.015  0.441
2017 Dickerson BC, McGinnis SM, Xia C, Price BH, Atri A, Murray ME, Mendez MF, Wolk DA. Approach to atypical Alzheimer's disease and case studies of the major subtypes. Cns Spectrums. 1-11. PMID 28196556 DOI: 10.1017/S109285291600047X  0.339
2016 Dong A, Toledo JB, Honnorat N, Doshi J, Varol E, Sotiras A, Wolk D, Trojanowski JQ, Davatzikos C. Heterogeneity of neuroanatomical patterns in prodromal Alzheimer's disease: links to cognition, progression and biomarkers. Brain : a Journal of Neurology. PMID 28003242 DOI: 10.1093/Brain/Aww319  0.487
2016 Quarmley M, Moberg PJ, Mechanic-Hamilton D, Kabadi S, Arnold SE, Wolk DA, Roalf DR. Odor Identification Screening Improves Diagnostic Classification in Incipient Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27886011 DOI: 10.3233/Jad-160842  0.545
2016 Wolk DA, Das SR, Mueller SG, Weiner MW, Yushkevich PA. Medial temporal lobe subregional morphometry using high resolution MRI in Alzheimer's disease. Neurobiology of Aging. PMID 27836336 DOI: 10.1016/J.Neurobiolaging.2016.09.011  0.387
2016 Roalf DR, Quarmley M, Mechanic-Hamilton D, Wolk DA, Arnold SE, Moberg PJ. Within-Individual Variability: An Index for Subtle Change in Neurocognition in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. 54: 325-35. PMID 27567827 DOI: 10.3233/Jad-160259  0.491
2016 Gertje EC, Pluta J, Das S, Mancuso L, Kliot D, Yushkevich P, Wolk D. Clinical Application of Automatic Segmentation of Medial Temporal Lobe Subregions in Prodromal and Dementia-Level Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 27567809 DOI: 10.3233/Jad-160014  0.429
2016 Tremel JJ, Laurent PA, Wolk DA, Wheeler ME, Fiez JA. Neural signatures of experience-based improvements in deterministic decision-making. Behavioural Brain Research. 315: 51-65. PMID 27523644 DOI: 10.1016/J.Bbr.2016.08.023  0.55
2016 Kandel BM, Avants BB, Gee JC, McMillan CT, Erus G, Doshi J, Davatzikos C, Wolk DA. White matter hyperintensities are more highly associated with preclinical Alzheimer's disease than imaging and cognitive markers of neurodegeneration. Alzheimer's & Dementia (Amsterdam, Netherlands). 4: 18-27. PMID 27489875 DOI: 10.1016/J.Dadm.2016.03.001  0.362
2016 Xie L, Dolui S, Das SR, Stockbower GE, Daffner M, Rao H, Yushkevich PA, Detre JA, Wolk DA. A brain stress test: Cerebral perfusion during memory encoding in mild cognitive impairment. Neuroimage. Clinical. 11: 388-97. PMID 27222794 DOI: 10.1016/J.Nicl.2016.03.002  0.304
2016 Roalf DR, Moore TM, Wolk DA, Arnold SE, Mechanic-Hamilton D, Rick J, Kabadi S, Ruparel K, Chen-Plotkin AS, Chahine LM, Dahodwala NA, Duda JE, Weintraub DA, Moberg PJ. Defining and validating a short form Montreal Cognitive Assessment (s-MoCA) for use in neurodegenerative disease. Journal of Neurology, Neurosurgery, and Psychiatry. PMID 27071646 DOI: 10.1136/Jnnp-2015-312723  0.488
2016 McMillan CT, Wolk D. F4-04-01: Biomarkers for Personalized Treatment of Neurodegenerative Spectrum Disease Alzheimer's & Dementia. 12: P327-P327. DOI: 10.1016/J.Jalz.2016.06.600  0.306
2016 Wisse LE, Das S, Yushkevich PA, Wolk D. IC-P-085: Suspected Non-Ad Pathology in Mild Cognitive Impairment: Defined by Cross-Sectional or Longitudinal Neurodegeneration Alzheimer's & Dementia. 12: P66-P66. DOI: 10.1016/J.Jalz.2016.06.114  0.38
2016 Das S, Phillips J, Wisse LE, Stockbower G, Ternes K, McMillan CT, Yushkevich PA, Grossman M, Nasrallah I, Wolk D. P1-265: TAU Binding Measured Using PET in Medial Temporal Lobe Correlates with Subregional Atrophy and Episodic Memory Performance In Alzheimer's Disease Alzheimer's & Dementia. 12: P515-P516. DOI: 10.1016/J.Jalz.2016.06.1015  0.399
2015 Wisse LE, Butala N, Das SR, Davatzikos C, Dickerson BC, Vaishnavi SN, Yushkevich PA, Wolk DA. Suspected non-AD pathology in mild cognitive impairment. Neurobiology of Aging. PMID 26422359 DOI: 10.1016/J.Neurobiolaging.2015.08.029  0.354
2015 Green DL, Payne L, Polikar R, Moberg PJ, Wolk DA, Kounios J. P50: A candidate ERP biomarker of prodromal Alzheimer׳s disease. Brain Research. 1624: 390-7. PMID 26256251 DOI: 10.1016/J.Brainres.2015.07.054  0.372
2015 Negash S, Kliot D, Howard DV, Howard JH, Das SR, Yushkevich PA, Pluta JB, Arnold SE, Wolk DA. Relationship of contextual cueing and hippocampal volume in amnestic mild cognitive impairment patients and cognitively normal older adults. Journal of the International Neuropsychological Society : Jins. 21: 285-96. PMID 25991413 DOI: 10.1017/S1355617715000223  0.442
2015 Ossenkoppele R, Jansen WJ, Rabinovici GD, Knol DL, van der Flier WM, van Berckel BN, Scheltens P, Visser PJ, Verfaillie SC, Zwan MD, Adriaanse SM, Lammertsma AA, Barkhof F, Jagust WJ, ... ... Wolk DA, et al. Prevalence of amyloid PET positivity in dementia syndromes: a meta-analysis. Jama. 313: 1939-49. PMID 25988463 DOI: 10.1001/Jama.2015.4669  0.314
2015 Jansen WJ, Ossenkoppele R, Knol DL, Tijms BM, Scheltens P, Verhey FR, Visser PJ, Aalten P, Aarsland D, Alcolea D, Alexander M, Almdahl IS, Arnold SE, Baldeiras I, ... ... Wolk DA, et al. Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis. Jama. 313: 1924-38. PMID 25988462 DOI: 10.1001/Jama.2015.4668  0.518
2015 Barnes J, Dickerson BC, Frost C, Jiskoot LC, Wolk D, van der Flier WM. Alzheimer's disease first symptoms are age dependent: Evidence from the NACC dataset. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 25916562 DOI: 10.1016/j.jalz.2014.12.007  0.411
2015 Kandel BM, Avants BB, Gee JC, Arnold SE, Wolk DA. Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment. Journal of Alzheimer's Disease : Jad. PMID 25881908 DOI: 10.3233/Jad-142943  0.539
2015 Das SR, Mancuso L, Olson IR, Arnold SE, Wolk DA. Short-Term Memory Depends on Dissociable Medial Temporal Lobe Regions in Amnestic Mild Cognitive Impairment. Cerebral Cortex (New York, N.Y. : 1991). PMID 25725042 DOI: 10.1093/Cercor/Bhv022  0.501
2015 Lyketsos C, Smith GS, Fosdick L, Leoutsakos JS, Munro C, Oh E, Drake K, Rosenberg P, Anderson WS, Salloway S, Pendergrass JC, Burke A, Wolk D, Foote K, Tang-Wai D, et al. DT-01-05: Deep brain stimulation targeting the fornix for mild Alzheimer's disease: Initial results of the advance randomized controlled trial Alzheimer's & Dementia. 11: P332-P333. DOI: 10.1016/J.Jalz.2015.08.155  0.35
2015 Wisse L, Butala N, Das S, Yushkevich P, Wolk D. Mild cognitive impairment patients with suspected non-alzheimer's disease pathology Alzheimers & Dementia. 11. DOI: 10.1016/J.Jalz.2015.07.067  0.453
2014 Nasrallah IM, Wolk DA. Multimodality imaging of Alzheimer disease and other neurodegenerative dementias. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55: 2003-11. PMID 25413136 DOI: 10.2967/jnumed.114.141416  0.339
2014 Glenn M, Mace L, Shaw L, Arnold S, Wolk D, Moelter S. A-79Primacy-Weighted Retrieval Differences in Healthy Older Adults with Pathological or Normal Cerebrospinal Fluid Markers of Alzheimer's Disease. Archives of Clinical Neuropsychology : the Official Journal of the National Academy of Neuropsychologists. 29: 532. PMID 25176741 DOI: 10.1093/Arclin/Acu038.79  0.534
2014 Toledo JB, Weiner MW, Wolk DA, Da X, Chen K, Arnold SE, Jagust W, Jack C, Reiman EM, Davatzikos C, Shaw LM, Trojanowski JQ. Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta Neuropathologica Communications. 2: 26. PMID 24602322 DOI: 10.1186/2051-5960-2-26  0.531
2014 Toledo JB, Da X, Weiner MW, Wolk DA, Xie SX, Arnold SE, Davatzikos C, Shaw LM, Trojanowski JQ. CSF Apo-E levels associate with cognitive decline and MRI changes. Acta Neuropathologica. 127: 621-32. PMID 24385135 DOI: 10.1007/S00401-013-1236-0  0.49
2014 Da X, Toledo JB, Zee J, Wolk DA, Xie SX, Ou Y, Shacklett A, Parmpi P, Shaw L, Trojanowski JQ, Davatzikos C. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers. Neuroimage. Clinical. 4: 164-73. PMID 24371799 DOI: 10.1016/J.Nicl.2013.11.010  0.351
2014 Toledo JB, Van Deerlin VM, Lee EB, Suh E, Baek Y, Robinson JL, Xie SX, McBride J, Wood EM, Schuck T, Irwin DJ, Gross RG, Hurtig H, McCluskey L, Elman L, ... ... Wolk D, et al. A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 10: 477-84.e1. PMID 23978324 DOI: 10.1016/J.Jalz.2013.06.003  0.503
2014 Karlawish J, Cary MS, Consentino S, Wolk D, Rubright JD, Harkins K. Which Self-Reported Cognitive Difficulties Differentiate Cognitively Normal Older Adults From Those With Mci? Alzheimers & Dementia. 10. DOI: 10.1016/J.Jalz.2014.05.906  0.333
2014 Dickerson B, Wolk DA. P2-213: AGE-ADJUSTED ALZHEIMER'S DISEASE SIGNATURE MRI BIOMARKER: CORRELATION WITH CSF TAU AND ABETA Alzheimer's & Dementia. 10: P550-P550. DOI: 10.1016/j.jalz.2014.05.890  0.3
2013 Wolk DA, Manning K, Kliot D, Arnold SE. Recognition memory in amnestic-mild cognitive impairment: insights from event-related potentials. Frontiers in Aging Neuroscience. 5: 89. PMID 24376418 DOI: 10.3389/Fnagi.2013.00089  0.508
2013 Steinberg SI, Negash S, Sammel MD, Bogner H, Harel BT, Livney MG, McCoubrey H, Wolk DA, Kling MA, Arnold SE. Subjective memory complaints, cognitive performance, and psychological factors in healthy older adults. American Journal of Alzheimer's Disease and Other Dementias. 28: 776-83. PMID 24363073 DOI: 10.1177/1533317513504817  0.46
2013 Wang Z, Das SR, Xie SX, Arnold SE, Detre JA, Wolk DA. Arterial spin labeled MRI in prodromal Alzheimer's disease: A multi-site study. Neuroimage. Clinical. 2: 630-6. PMID 24179814 DOI: 10.1016/J.Nicl.2013.04.014  0.557
2013 Wolk DA. Amyloid imaging in atypical presentations of Alzheimer's disease. Current Neurology and Neuroscience Reports. 13: 412. PMID 24136459 DOI: 10.1007/s11910-013-0412-x  0.37
2013 Dickerson BC, Wolk DA. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau. Frontiers in Aging Neuroscience. 5: 55. PMID 24130528 DOI: 10.3389/fnagi.2013.00055  0.343
2013 Yarchoan M, Louneva N, Xie SX, Swenson FJ, Hu W, Soares H, Trojanowski JQ, Lee VM, Kling MA, Shaw LM, Chen-Plotkin A, Wolk DA, Arnold SE. Association of plasma C-reactive protein levels with the diagnosis of Alzheimer's disease. Journal of the Neurological Sciences. 333: 9-12. PMID 23978419 DOI: 10.1016/J.Jns.2013.05.028  0.523
2013 Negash S, Wilson RS, Leurgans SE, Wolk DA, Schneider JA, Buchman AS, Bennett DA, Arnold SE. Resilient brain aging: characterization of discordance between Alzheimer's disease pathology and cognition. Current Alzheimer Research. 10: 844-51. PMID 23919768 DOI: 10.2174/15672050113109990157  0.524
2013 Arnold SE, Toledo JB, Appleby DH, Xie SX, Wang LS, Baek Y, Wolk DA, Lee EB, Miller BL, Lee VM, Trojanowski JQ. Comparative survey of the topographical distribution of signature molecular lesions in major neurodegenerative diseases. The Journal of Comparative Neurology. 521: 4339-55. PMID 23881776 DOI: 10.1002/Cne.23430  0.479
2013 Bakkour A, Morris JC, Wolk DA, Dickerson BC. The effects of aging and Alzheimer's disease on cerebral cortical anatomy: specificity and differential relationships with cognition. Neuroimage. 76: 332-44. PMID 23507382 DOI: 10.1016/J.Neuroimage.2013.02.059  0.304
2013 Wolk DA, Mancuso L, Kliot D, Arnold SE, Dickerson BC. Familiarity-based memory as an early cognitive marker of preclinical and prodromal AD. Neuropsychologia. 51: 1094-102. PMID 23474075 DOI: 10.1016/J.Neuropsychologia.2013.02.014  0.603
2013 Toledo JB, Da X, Bhatt P, Wolk DA, Arnold SE, Shaw LM, Trojanowski JQ, Davatzikos C. Relationship between plasma analytes and SPARE-AD defined brain atrophy patterns in ADNI. Plos One. 8: e55531. PMID 23408997 DOI: 10.1371/Journal.Pone.0055531  0.506
2013 McMillan CT, Avants B, Irwin DJ, Toledo JB, Wolk DA, Van Deerlin VM, Shaw LM, Trojanoswki JQ, Grossman M. Can MRI screen for CSF biomarkers in neurodegenerative disease? Neurology. 80: 132-8. PMID 23269595 DOI: 10.1212/Wnl.0B013E31827B9147  0.304
2013 Roalf DR, Moberg PJ, Xie SX, Wolk DA, Moelter ST, Arnold SE. Comparative accuracies of two common screening instruments for classification of Alzheimer's disease, mild cognitive impairment, and healthy aging. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 529-37. PMID 23260866 DOI: 10.1016/J.Jalz.2012.10.001  0.542
2013 Kling MA, Trojanowski JQ, Wolk DA, Lee VM, Arnold SE. Vascular disease and dementias: paradigm shifts to drive research in new directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: 76-92. PMID 23183137 DOI: 10.1016/J.Jalz.2012.02.007  0.511
2013 Negash S, Xie S, Davatzikos C, Clark CM, Trojanowski JQ, Shaw LM, Wolk DA, Arnold SE. Cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 9: e89-95. PMID 23127468 DOI: 10.1016/J.Jalz.2012.01.009  0.571
2013 Irwin DJ, McMillan CT, Brettschneider J, Libon DJ, Powers J, Rascovsky K, Toledo JB, Boller A, Bekisz J, Chandrasekaran K, Wood EM, Shaw LM, Woo JH, Cook PA, Wolk DA, et al. Cognitive decline and reduced survival in C9orf72 expansion frontotemporal degeneration and amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 163-9. PMID 23117491 DOI: 10.1136/Jnnp-2012-303507  0.416
2013 Arnold SE, Vega IE, Karlawish JH, Wolk DA, Nunez J, Negron M, Xie SX, Wang LS, Dubroff JG, McCarty-Wood E, Trojanowski JQ, Van Deerlin V. Frequency and clinicopathological characteristics of presenilin 1 Gly206Ala mutation in Puerto Rican Hispanics with dementia. Journal of Alzheimer's Disease : Jad. 33: 1089-95. PMID 23114514 DOI: 10.3233/Jad-2012-121570  0.494
2013 Arnold SE, Louneva N, Cao K, Wang LS, Han LY, Wolk DA, Negash S, Leurgans SE, Schneider JA, Buchman AS, Wilson RS, Bennett DA. Cellular, synaptic, and biochemical features of resilient cognition in Alzheimer's disease. Neurobiology of Aging. 34: 157-68. PMID 22554416 DOI: 10.1016/J.Neurobiolaging.2012.03.004  0.555
2013 Dickerson B, Wolk D. Cerebrospinal fluid tau levels increase with age and are associated with neurodegeneration even in the absence of cerebral amyloid Alzheimers & Dementia. 9: 699. DOI: 10.1016/J.Jalz.2013.04.380  0.331
2013 Wolk D, Dickerson B. S1-02-04: Neurodegenerative predictors of decline in MCI: Relationship to amyloid status Alzheimer's & Dementia. 9: P122-P123. DOI: 10.1016/j.jalz.2013.04.039  0.398
2012 Yarchoan M, Xie SX, Kling MA, Toledo JB, Wolk DA, Lee EB, Van Deerlin V, Lee VM, Trojanowski JQ, Arnold SE. Cerebrovascular atherosclerosis correlates with Alzheimer pathology in neurodegenerative dementias. Brain : a Journal of Neurology. 135: 3749-56. PMID 23204143 DOI: 10.1093/Brain/Aws271  0.534
2012 Rinne JO, Wong DF, Wolk DA, Leinonen V, Arnold SE, Buckley C, Smith A, McLain R, Sherwin PF, Farrar G, Kailajärvi M, Grachev ID. [(18)F]Flutemetamol PET imaging and cortical biopsy histopathology for fibrillar amyloid β detection in living subjects with normal pressure hydrocephalus: pooled analysis of four studies. Acta Neuropathologica. 124: 833-45. PMID 23053137 DOI: 10.1007/S00401-012-1051-Z  0.503
2012 Naylor MD, Karlawish JH, Arnold SE, Khachaturian AS, Khachaturian ZS, Lee VM, Baumgart M, Banerjee S, Beck C, Blennow K, Brookmeyer R, Brunden KR, Buckwalter KC, Comer M, Covinsky K, ... ... Wolk DA, et al. Advancing Alzheimer's disease diagnosis, treatment, and care: recommendations from the Ware Invitational Summit. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 445-52. PMID 22959699 DOI: 10.1016/J.Jalz.2012.08.001  0.461
2012 Zhang Q, Stafford RB, Wang Z, Arnold SE, Wolk DA, Detre JA. Microvascular perfusion based on arterial spin labeled perfusion MRI as a measure of vascular risk in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 32: 677-87. PMID 22886015 DOI: 10.3233/Jad-2012-120964  0.529
2012 Arnold SE, Xie SX, Leung YY, Wang LS, Kling MA, Han X, Kim EJ, Wolk DA, Bennett DA, Chen-Plotkin A, Grossman M, Hu W, Lee VM, Mackin RS, Trojanowski JQ, et al. Plasma biomarkers of depressive symptoms in older adults. Translational Psychiatry. 2: e65. PMID 22832727 DOI: 10.1038/Tp.2011.63  0.478
2012 Wolk DA, Zhang Z, Boudhar S, Clark CM, Pontecorvo MJ, Arnold SE. Amyloid imaging in Alzheimer's disease: comparison of florbetapir and Pittsburgh compound-B positron emission tomography. Journal of Neurology, Neurosurgery, and Psychiatry. 83: 923-6. PMID 22791901 DOI: 10.1136/Jnnp-2012-302548  0.502
2012 Wolk DA, Detre JA. Arterial spin labeling MRI: an emerging biomarker for Alzheimer's disease and other neurodegenerative conditions. Current Opinion in Neurology. 25: 421-8. PMID 22610458 DOI: 10.1097/WCO.0b013e328354ff0a  0.326
2012 Pluta J, Yushkevich P, Das S, Wolk D. In vivo analysis of hippocampal subfield atrophy in mild cognitive impairment via semi-automatic segmentation of T2-weighted MRI. Journal of Alzheimer's Disease : Jad. 31: 85-99. PMID 22504319 DOI: 10.3233/Jad-2012-111931  0.328
2012 Bakken TE, Roddey JC, Djurovic S, Akshoomoff N, Amaral DG, Bloss CS, Casey BJ, Chang L, Ernst TM, Gruen JR, Jernigan TL, Kaufmann WE, Kenet T, Kennedy DN, Kuperman JM, ... ... Wolk D, et al. Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans. Proceedings of the National Academy of Sciences of the United States of America. 109: 3985-90. PMID 22343285 DOI: 10.1073/Pnas.1105829109  0.345
2012 Wolk DA, Price JC, Madeira C, Saxton JA, Snitz BE, Lopez OL, Mathis CA, Klunk WE, DeKosky ST. Amyloid imaging in dementias with atypical presentation. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 389-98. PMID 22285638 DOI: 10.1016/J.Jalz.2011.07.003  0.343
2012 Dickerson BC, Wolk DA. MRI cortical thickness biomarker predicts AD-like CSF and cognitive decline in normal adults. Neurology. 78: 84-90. PMID 22189451 DOI: 10.1212/WNL.0b013e31823efc6c  0.359
2012 Weintraub D, Dietz N, Duda JE, Wolk DA, Doshi J, Xie SX, Davatzikos C, Clark CM, Siderowf A. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease. Brain : a Journal of Neurology. 135: 170-80. PMID 22108576 DOI: 10.1093/Brain/Awr277  0.366
2012 Musiek ES, Chen Y, Korczykowski M, Saboury B, Martinez PM, Reddin JS, Alavi A, Kimberg DY, Wolk DA, Julin P, Newberg AB, Arnold SE, Detre JA. Direct comparison of fluorodeoxyglucose positron emission tomography and arterial spin labeling magnetic resonance imaging in Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 8: 51-9. PMID 22018493 DOI: 10.1016/J.Jalz.2011.06.003  0.472
2012 Wolk D, Rinne J, Wong D, Leinonen V, Arnold S, Buckley C, Smith A, McLain R, Sherwin P, Farrar G, Kailajarvi M, Grachev I. [18F]-Flutemetamol PET Amyloid Imaging and Cortical Biopsy Histopathology in Normal Pressure Hydrocephalus: Pooled Analysis of Four Studies (IN3-1.009) Neurology. 78: IN3-1.009-IN3-1.009. DOI: 10.1212/Wnl.78.1_Meetingabstracts.In3-1.009  0.519
2012 Farnum M, Baek Y, Schultz T, Nefedov A, Xie S, Leung YY, Toledo J, Raghavan N, Chen-Plotkin A, Wolk D, Polikar R, DiBernardo A, Siderowf A, Davatzikos C, Van Deerlin V, et al. P1-006: An integrated approach to the development of biomarkers for Alzheimer's disease using hospital population data Alzheimer's & Dementia. 8: P109-P109. DOI: 10.1016/J.Jalz.2012.05.281  0.512
2012 Arnold S, Rinne J, Wong D, Leinonen V, Wolk D, Buckley C, Smith A, McLain R, Sherwin P, Farrar G, Kailajarvi M, Grachev I. Prospective and retrospective evaluation of [18F]Flutemetamol for beta-amyloid detection in the brain of living subjects with normal pressure hydrocephalus Alzheimers & Dementia. 8: 91. DOI: 10.1016/J.Jalz.2012.05.224  0.472
2012 Leung YY, Wang L, Hu WT, Kling M, Wolk D, Trojanowski J, Lee V, Shaw L, Arnold S. P2-049: Cerebrospinal fluid biochemical biomarkers of depressive symptoms in older adults Alzheimer's & Dementia. 8: P280-P280. DOI: 10.1016/J.Jalz.2012.05.2143  0.448
2012 Jicha G, Cecchi M, Doraiswamy PM, Solomon P, Arnold S, Wolk D, Casey D, Smith C, Kulkarni M. P2-407: A multicenter clinical trial to validate Event-Related Potentials (ERPs) as useful biomarkers for early detection of Alzheimer's Alzheimer's & Dementia. 8: P406-P407. DOI: 10.1016/J.Jalz.2012.05.2032  0.503
2012 Toledo J, Yotter R, Da X, Bhatt P, Wolk D, Arnold S, Shaw L, Trojanowski J, Davatzikos C. O5-04-03: Relationship between plasma analytes and SPARE-Alzheimer's disease defined patterns of brain atrophy in ADNI Alzheimer's & Dementia. 8: P737-P738. DOI: 10.1016/J.Jalz.2012.05.1989  0.511
2011 Chen Y, Wolk DA, Reddin JS, Korczykowski M, Martinez PM, Musiek ES, Newberg AB, Julin P, Arnold SE, Greenberg JH, Detre JA. Voxel-level comparison of arterial spin-labeled perfusion MRI and FDG-PET in Alzheimer disease. Neurology. 77: 1977-85. PMID 22094481 DOI: 10.1212/Wnl.0B013E31823A0Ef7  0.481
2011 Wolk DA, Grachev ID, Buckley C, Kazi H, Grady MS, Trojanowski JQ, Hamilton RH, Sherwin P, McLain R, Arnold SE. Association between in vivo fluorine 18-labeled flutemetamol amyloid positron emission tomography imaging and in vivo cerebral cortical histopathology. Archives of Neurology. 68: 1398-403. PMID 21747004 DOI: 10.1001/Archneurol.2011.153  0.466
2011 Wilckens KA, Tremel JJ, Wolk DA, Wheeler ME. Effects of task-set adoption on ERP correlates of controlled and automatic recognition memory. Neuroimage. 55: 1384-92. PMID 21211568 DOI: 10.1016/j.neuroimage.2010.12.059  0.559
2011 Dickerson BC, Wolk DA. Dysexecutive versus amnesic phenotypes of very mild Alzheimer's disease are associated with distinct clinical, genetic and cortical thinning characteristics. Journal of Neurology, Neurosurgery, and Psychiatry. 82: 45-51. PMID 20562467 DOI: 10.1136/jnnp.2009.199505  0.342
2011 Fleisher A, Wolk D. Ask the experts: PET amyloid imaging: can its diagnostic potential be effectively realized in the clinic? Neurodegenerative Disease Management. 1: 445-451. DOI: 10.2217/NMT.11.73  0.306
2011 Negash S, Xie SX, Davatzikos C, Wolk D, Arnold S. P2-053: Factors associated with cognitive and functional resilience despite molecular evidence of Alzheimer's disease pathology Alzheimer's & Dementia. 7: S324-S324. DOI: 10.1016/J.Jalz.2011.05.942  0.582
2011 Arnold S, Xie SX, Leung Y, Kim E, Kling M, Wilson R, Bennett D, Hu W, Mackin S, Grossman M, Chen-Plotkin A, Wolk D, Lee V, Trojanowski J, Shaw L. P2-017: Biochemical Biomarkers of Depressive Symptoms in ADNI Alzheimer's & Dementia. 7: S312-S312. DOI: 10.1016/J.Jalz.2011.05.907  0.431
2011 Dickerson B, Wolk D. P1-311: Testing the new diagnostic criteria for Preclinical Alzheimer's disease: MRI biomarker of Alzheimer's disease-related atrophy in cognitively normal individuals predicts cognitive decline Alzheimer's & Dementia. 7: S210-S210. DOI: 10.1016/j.jalz.2011.05.590  0.464
2011 Wolk D, Grachev I, Buckley C, Heurling K, Hamilton R, Arnold S. [18F]-Flutemetamol amyloid PET imaging in patients with normal pressure hydrocephalus Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.2099  0.47
2011 Dickerson B, Wolk D. IC-P-041: Testing the new diagnostic criteria for Preclinical Alzheimer's Disease: MRI biomarker of Alzheimer's disease-related atrophy in cognitively normal individuals predicts cognitive decline Alzheimer's & Dementia. 7: S25-S25. DOI: 10.1016/j.jalz.2011.05.110  0.353
2010 Wolk DA, Dickerson BC. Apolipoprotein E (APOE) genotype has dissociable effects on memory and attentional-executive network function in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America. 107: 10256-61. PMID 20479234 DOI: 10.1073/pnas.1001412107  0.374
2009 Wolk DA, Klunk W. Update on amyloid imaging: from healthy aging to Alzheimer's disease. Current Neurology and Neuroscience Reports. 9: 345-52. PMID 19664363 DOI: 10.1007/s11910-009-0051-4  0.351
2009 Wolk DA, Price JC, Saxton JA, Snitz BE, James JA, Lopez OL, Aizenstein HJ, Cohen AD, Weissfeld LA, Mathis CA, Klunk WE, De-Kosky ST, DeKoskym ST. Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology. 65: 557-68. PMID 19475670 DOI: 10.1002/Ana.21598  0.352
2009 Phillips JS, Velanova K, Wolk DA, Wheeler ME. Left posterior parietal cortex participates in both task preparation and episodic retrieval. Neuroimage. 46: 1209-21. PMID 19285142 DOI: 10.1016/j.neuroimage.2009.02.044  0.568
2009 Cohen AD, Price JC, Weissfeld LA, James J, Saxton J, Snitz B, Aizenstein H, Wolk D, DeKosky ST, Mathis CA, Klunk WE. O1-01-02: Patterns of correlation between Aβ deposition and glucose metabolism across the spectrum of mild cognitive impairment to Alzheimer's disease Alzheimer's & Dementia. 5: P76-P76. DOI: 10.1016/J.Jalz.2009.05.188  0.404
2005 Wolk DA, Schacter DL, Berman AR, Holcomb PJ, Daffner KR, Budson AE. Patients with mild Alzheimer's disease attribute conceptual fluency to prior experience. Neuropsychologia. 43: 1662-72. PMID 16009248 DOI: 10.1016/J.Neuropsychologia.2005.01.007  0.307
Show low-probability matches.